G-protein-coupled receptor dimerization: Modulation of receptor function

C. D. Rios, Bryen A. Jordan, I. Gomes, L. A. Devi

Research output: Contribution to journalArticle

275 Citations (Scopus)

Abstract

G-protein-coupled receptors (GPCRs) comprise the largest family of transmembrane receptors in the human genome that respond to a plethora of signals, including neurotransmitters, peptide hormones, and odorants, to name a few. They couple to second messenger signaling cascade mechanisms via heterotrimeric G-proteins. Recently, many studies have revealed that GPCRs exist as dimers, which may be present as homo- or heterodimers/oligomers. These recent findings have been met with skepticism, since they are contradictory to the dogma that GPCRs function as monomers. Although the existence of GPCR dimers/oligomers was predicted from early pharmacological and biochemical studies, further studies to critically evaluate this phenomenon were impeded by the lack of appropriate reagents. The availability of cDNAs for GPCRs, of highly selective ligands and of antibodies for these receptors has made it possible to visualize and investigate the functional effects of GPCR oligomers. Pharmacological studies, along with biochemical techniques, such as cross-linking and immunoprecipitation with differentially epitope-tagged receptors, have been employed to demonstrate the oligomerization of a number of GPCRs. Moreover, recent biophysical techniques, such as bioluminescence and fluorescence resonance energy transfer, now make it possible to examine GPCR dimerization/oligomerization in living cells. In this review, we provide a brief overview of some of the techniques employed to describe GPCR dimers, and we discuss their respective limitations. We also examine the implications of dimerization/oligomerization on GPCR function. In addition, we discuss domains of the receptors that are thought to facilitate dimerization/oligomerization. Finally, we consider recent evidence for the subcellular localization of the dimer/oligomer assembly.

Original languageEnglish (US)
Pages (from-to)71-87
Number of pages17
JournalPharmacology and Therapeutics
Volume92
Issue number2-3
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Dimerization
G-Protein-Coupled Receptors
Pharmacology
Heterotrimeric GTP-Binding Proteins
Fluorescence Resonance Energy Transfer
Peptide Hormones
Second Messenger Systems
Human Genome
Immunoprecipitation
Names
Neurotransmitter Agents
Epitopes
Complementary DNA
Ligands
Antibodies

Keywords

  • Bioluminescence resonance energy transfer
  • Desensitization
  • GPCR maturation
  • Oligomerization
  • Opioids
  • Protein-protein interaction

ASJC Scopus subject areas

  • Pharmacology

Cite this

G-protein-coupled receptor dimerization : Modulation of receptor function. / Rios, C. D.; Jordan, Bryen A.; Gomes, I.; Devi, L. A.

In: Pharmacology and Therapeutics, Vol. 92, No. 2-3, 2001, p. 71-87.

Research output: Contribution to journalArticle

Rios, C. D. ; Jordan, Bryen A. ; Gomes, I. ; Devi, L. A. / G-protein-coupled receptor dimerization : Modulation of receptor function. In: Pharmacology and Therapeutics. 2001 ; Vol. 92, No. 2-3. pp. 71-87.
@article{19f88dbea0784f438fa002ca27e5ddd5,
title = "G-protein-coupled receptor dimerization: Modulation of receptor function",
abstract = "G-protein-coupled receptors (GPCRs) comprise the largest family of transmembrane receptors in the human genome that respond to a plethora of signals, including neurotransmitters, peptide hormones, and odorants, to name a few. They couple to second messenger signaling cascade mechanisms via heterotrimeric G-proteins. Recently, many studies have revealed that GPCRs exist as dimers, which may be present as homo- or heterodimers/oligomers. These recent findings have been met with skepticism, since they are contradictory to the dogma that GPCRs function as monomers. Although the existence of GPCR dimers/oligomers was predicted from early pharmacological and biochemical studies, further studies to critically evaluate this phenomenon were impeded by the lack of appropriate reagents. The availability of cDNAs for GPCRs, of highly selective ligands and of antibodies for these receptors has made it possible to visualize and investigate the functional effects of GPCR oligomers. Pharmacological studies, along with biochemical techniques, such as cross-linking and immunoprecipitation with differentially epitope-tagged receptors, have been employed to demonstrate the oligomerization of a number of GPCRs. Moreover, recent biophysical techniques, such as bioluminescence and fluorescence resonance energy transfer, now make it possible to examine GPCR dimerization/oligomerization in living cells. In this review, we provide a brief overview of some of the techniques employed to describe GPCR dimers, and we discuss their respective limitations. We also examine the implications of dimerization/oligomerization on GPCR function. In addition, we discuss domains of the receptors that are thought to facilitate dimerization/oligomerization. Finally, we consider recent evidence for the subcellular localization of the dimer/oligomer assembly.",
keywords = "Bioluminescence resonance energy transfer, Desensitization, GPCR maturation, Oligomerization, Opioids, Protein-protein interaction",
author = "Rios, {C. D.} and Jordan, {Bryen A.} and I. Gomes and Devi, {L. A.}",
year = "2001",
doi = "10.1016/S0163-7258(01)00160-7",
language = "English (US)",
volume = "92",
pages = "71--87",
journal = "Pharmacology and Therapeutics",
issn = "0163-7258",
publisher = "Elsevier Inc.",
number = "2-3",

}

TY - JOUR

T1 - G-protein-coupled receptor dimerization

T2 - Modulation of receptor function

AU - Rios, C. D.

AU - Jordan, Bryen A.

AU - Gomes, I.

AU - Devi, L. A.

PY - 2001

Y1 - 2001

N2 - G-protein-coupled receptors (GPCRs) comprise the largest family of transmembrane receptors in the human genome that respond to a plethora of signals, including neurotransmitters, peptide hormones, and odorants, to name a few. They couple to second messenger signaling cascade mechanisms via heterotrimeric G-proteins. Recently, many studies have revealed that GPCRs exist as dimers, which may be present as homo- or heterodimers/oligomers. These recent findings have been met with skepticism, since they are contradictory to the dogma that GPCRs function as monomers. Although the existence of GPCR dimers/oligomers was predicted from early pharmacological and biochemical studies, further studies to critically evaluate this phenomenon were impeded by the lack of appropriate reagents. The availability of cDNAs for GPCRs, of highly selective ligands and of antibodies for these receptors has made it possible to visualize and investigate the functional effects of GPCR oligomers. Pharmacological studies, along with biochemical techniques, such as cross-linking and immunoprecipitation with differentially epitope-tagged receptors, have been employed to demonstrate the oligomerization of a number of GPCRs. Moreover, recent biophysical techniques, such as bioluminescence and fluorescence resonance energy transfer, now make it possible to examine GPCR dimerization/oligomerization in living cells. In this review, we provide a brief overview of some of the techniques employed to describe GPCR dimers, and we discuss their respective limitations. We also examine the implications of dimerization/oligomerization on GPCR function. In addition, we discuss domains of the receptors that are thought to facilitate dimerization/oligomerization. Finally, we consider recent evidence for the subcellular localization of the dimer/oligomer assembly.

AB - G-protein-coupled receptors (GPCRs) comprise the largest family of transmembrane receptors in the human genome that respond to a plethora of signals, including neurotransmitters, peptide hormones, and odorants, to name a few. They couple to second messenger signaling cascade mechanisms via heterotrimeric G-proteins. Recently, many studies have revealed that GPCRs exist as dimers, which may be present as homo- or heterodimers/oligomers. These recent findings have been met with skepticism, since they are contradictory to the dogma that GPCRs function as monomers. Although the existence of GPCR dimers/oligomers was predicted from early pharmacological and biochemical studies, further studies to critically evaluate this phenomenon were impeded by the lack of appropriate reagents. The availability of cDNAs for GPCRs, of highly selective ligands and of antibodies for these receptors has made it possible to visualize and investigate the functional effects of GPCR oligomers. Pharmacological studies, along with biochemical techniques, such as cross-linking and immunoprecipitation with differentially epitope-tagged receptors, have been employed to demonstrate the oligomerization of a number of GPCRs. Moreover, recent biophysical techniques, such as bioluminescence and fluorescence resonance energy transfer, now make it possible to examine GPCR dimerization/oligomerization in living cells. In this review, we provide a brief overview of some of the techniques employed to describe GPCR dimers, and we discuss their respective limitations. We also examine the implications of dimerization/oligomerization on GPCR function. In addition, we discuss domains of the receptors that are thought to facilitate dimerization/oligomerization. Finally, we consider recent evidence for the subcellular localization of the dimer/oligomer assembly.

KW - Bioluminescence resonance energy transfer

KW - Desensitization

KW - GPCR maturation

KW - Oligomerization

KW - Opioids

KW - Protein-protein interaction

UR - http://www.scopus.com/inward/record.url?scp=0035726693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035726693&partnerID=8YFLogxK

U2 - 10.1016/S0163-7258(01)00160-7

DO - 10.1016/S0163-7258(01)00160-7

M3 - Article

C2 - 11916530

AN - SCOPUS:0035726693

VL - 92

SP - 71

EP - 87

JO - Pharmacology and Therapeutics

JF - Pharmacology and Therapeutics

SN - 0163-7258

IS - 2-3

ER -